Nutex Health (NASDAQ:NUTX) Stock Rated “Buy” in New Coverage at LADENBURG THALM/SH SH

Investment analysts at LADENBURG THALM/SH SH started coverage on shares of Nutex Health (NASDAQ:NUTX) in a report issued on Monday, Briefing.com reports. The brokerage set a “buy” rating and a $336.00 price target on the stock. LADENBURG THALM/SH SH‘s price objective suggests a potential upside of 60.31% from the stock’s previous close.

Several other analysts have also issued reports on the stock. Zacks Research lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Lake Street Capital reaffirmed a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, October 6th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $323.67.

Nutex Health Price Performance

Nutex Health stock opened at $209.59 on Monday. The stock has a market capitalization of $1.44 billion, a P/E ratio of 8.23 and a beta of 0.55. The company’s fifty day moving average price is $201.41 and its 200 day moving average price is $163.35. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. Nutex Health has a 1 year low of $83.99 and a 1 year high of $226.16.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. As a group, equities research analysts anticipate that Nutex Health will post 27.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the transaction, the director directly owned 400 shares of the company’s stock, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Sterling Capital Management LLC boosted its stake in Nutex Health by 9.1% during the 3rd quarter. Sterling Capital Management LLC now owns 1,771 shares of the company’s stock worth $375,000 after purchasing an additional 148 shares during the last quarter. Cantor Fitzgerald Investment Advisors L.P. acquired a new stake in shares of Nutex Health in the third quarter valued at about $2,117,000. State of Alaska Department of Revenue raised its position in shares of Nutex Health by 243.6% in the third quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company’s stock valued at $211,000 after buying an additional 709 shares during the last quarter. GK Wealth Management LLC acquired a new stake in shares of Nutex Health in the third quarter valued at about $73,000. Finally, WINTON GROUP Ltd purchased a new position in shares of Nutex Health in the second quarter worth about $237,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.